Finally, we reported inhibition of TGFβ/SMAD pathway (by TGFβ inhibitor LY2157299 or SMAD4 siRNA) could reverse the tumor‐promoting effects caused by CKS2. This evidence concerns the gene CKS2 and neoplasm.